Archive for the ‘Traversa Therapeutics’ Category

Traversa Therapeutics

January 12th, 2010 | Posted in Traversa Therapeutics

Traversa Therapeutics, San Diego, is a preclinical-stage biopharmaceutical company which develops novel RNA interference RNAi technologies.  The company has appointed Curt W. Bradshaw, Ph.D. as VP of Research & Development.